14
Covaxin vaccine

Why did WHO suspend supply of Covaxin through UN agencies?

1:23
31
Views
0
Likes
6/27/2022

The data available to WHO as of 2 April 2022 indicate that the vaccine is safe and effective.

The supply of Covaxin (manufactured by Bharat Biotech) through UN procurement agencies was suspended (as of 2 April 2022) in response to the outcome of a WHO inspection on 14–22 March 2022, and the need to conduct process and facility upgrade to address recently identified deficiencies in good manufacturing practices (GMP).

Bharat Biotech has committed to addressing the GMP deficiencies, and is developing a corrective and preventive action plan for submission to the Drugs Controller General of India (DCGI) and WHO. In the interim and as a precautionary measure, the company indicated that it would suspend production of Covaxin for export. As a consequence, supply will be interrupted for the foreseeable future.

Tags